» Articles » PMID: 37569884

Role of TRP Channels in Liver-Related Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Aug 12
PMID 37569884
Authors
Affiliations
Soon will be listed here.
Abstract

The liver plays a crucial role in preserving the homeostasis of an entire organism by metabolizing both endogenous and exogenous substances, a process that relies on the harmonious interactions of hepatocytes, hepatic stellate cells (HSCs), Kupffer cells (KCs), and vascular endothelial cells (ECs). The disruption of the liver's normal structure and function by diverse pathogenic factors imposes a significant healthcare burden. At present, most of the treatments for liver disease are palliative in nature, rather than curative or restorative. Transient receptor potential (TRP) channels, which are extensively expressed in the liver, play a crucial role in regulating intracellular cation concentration and serve as the origin or intermediary stage of certain signaling pathways that contribute to liver diseases. This review provides an overview of recent developments in liver disease research, as well as an examination of the expression and function of TRP channels in various liver cell types. Furthermore, we elucidate the molecular mechanism by which TRP channels mediate liver injury, liver fibrosis, and hepatocellular carcinoma (HCC). Ultimately, the present discourse delves into the current state of research and extant issues pertaining to the targeting of TRP channels in the treatment of liver diseases and other ailments. Despite the numerous obstacles encountered, TRP channels persist as an extremely important target for forthcoming clinical interventions aimed at treating liver diseases.

Citing Articles

Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review).

Yu M, Yu H, Wang H, Xu X, Sun Z, Chen W Int J Oncol. 2024; 65(4).

PMID: 39239752 PMC: 11387121. DOI: 10.3892/ijo.2024.5688.


Role of TRP Channels in Metabolism-Related Diseases.

Wu F, Bu S, Wang H Int J Mol Sci. 2024; 25(2).

PMID: 38255767 PMC: 10815096. DOI: 10.3390/ijms25020692.

References
1.
Von Moos R, Strasser F, Gillessen S, Zaugg K . Metastatic bone pain: treatment options with an emphasis on bisphosphonates. Support Care Cancer. 2008; 16(10):1105-15. DOI: 10.1007/s00520-008-0487-0. View

2.
Kheradpezhouh E, Zhou F, Barritt G, Rychkov G . Oxidative stress promotes redistribution of TRPM2 channels to the plasma membrane in hepatocytes. Biochem Biophys Res Commun. 2018; 503(3):1891-1896. DOI: 10.1016/j.bbrc.2018.07.132. View

3.
Phe V, Schneider M, Peyronnet B, Abo Youssef N, Mordasini L, Chartier-Kastler E . Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society.... Neurourol Urodyn. 2017; 37(1):67-82. DOI: 10.1002/nau.23314. View

4.
Webb B, Chimenti M, Jacobson M, Barber D . Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer. 2011; 11(9):671-7. DOI: 10.1038/nrc3110. View

5.
Liu Q, Lei X, Cao Z, Zhang J, Yan L, Fu J . TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling. Cell Biosci. 2022; 12(1):58. PMC: 9080211. DOI: 10.1186/s13578-022-00789-4. View